|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Income from cash and investments held in Trust Account | |||||
| Write-off contingent warrants associated with shares redeemed | |||||
| Stock based compensation | |||||
| Gain on extinguishment of liability | |||||
| Amortization of debt discount and debt issuance costs | |||||
| Finance charges | |||||
| Synthetic ATM commitment fee | |||||
| Loss from change in fair value of common stock make-whole obligation | |||||
| Loss on sale of investments | |||||
| Change in fair value of investment in equity securities | |||||
| Change in fair value of SAFE notes | |||||
| Loss on write-off of promissory notes and deposit | |||||
| Change in fair value of warrant liability | |||||
| Change in fair value of 2024 convertible notes | |||||
| Change in fair value of sponsor earnout shares | |||||
| Non-cash marketing expense for proposed stock issuance to vendor | |||||
| Depreciation expense | |||||
| Loss on write off of deferred transaction cost | |||||
| Changes in operating assets and liabilities: | |||||
| (Increase) decrease in prepaid expenses | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Increase (decrease) in accrued liabilities and other | |||||
| Accrued liabilities and other current liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Cash deposited in Trust Account | |||||
| Cash withdrawn from Trust Account to pay redemptions | |||||
| Capital project costs | |||||
| Land acquisition costs | |||||
| Investment in equity securities | |||||
| Proceeds from sale of investment in equity securities | |||||
| Investment in other long-term assets | |||||
| Purchase of property and equipment | |||||
| Promissory notes issued | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Redemption of 26,068,281 Class A common shares | |||||
| Advances and repayment of promissory note – related party | |||||
| Proceeds of Extension Promissory Note – related party | |||||
| Net proceeds | |||||
| Payment of equity issuance costs | |||||
| Proceeds from issuance of notes payable to related parties | |||||
| Repayment of notes payable to related parties | |||||
| Proceeds from short-term loan from related parties (Note 16) | |||||
| Repayment of short-term loan from related parties (Note 16) | |||||
| Proceeds from short-term loan | |||||
| Repayment of short-term loan | |||||
| Proceeds from advance received from PIPE investor | |||||
| Proceeds from investor for issuance of SAFE notes | |||||
| Aggregate gross proceeds | |||||
| Proceeds from warrant inducement exercises | |||||
| Transaction costs associated with public offerings and warrant inducement | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from issuance of convertible notes | |||||
| Proceeds from issuance of convertible notes and warrants, net of transaction costs | |||||
| Deferred transaction costs paid | |||||
| Proceeds from business combination and issuance of PIPE shares | |||||
| Transaction costs associated with issuance of common stock upon warrant exchange | |||||
| Repayment of sponsor promissory notes | |||||
| Repurchase of unvested shares | |||||
| Payments for fractional share adjustment due to reverse stock split | |||||
| Net cash provided by financing activities | |||||
| Net increase/(decrease) in cash | |||||
| Cash at the beginning of the period | |||||
| Cash at the end of the period | |||||
| Settlement and release of liabilities | |||||
| Supplemental disclosure for cash flow information: | |||||
| Interest paid | |||||
| Taxes paid | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Unpaid deferred transaction costs | |||||
| Conversion of legacy SAFE notes | |||||
| Conversion of legacy convertible notes | |||||
| Sponsor earnout share liability | |||||
| Issuance of common stock to Sponsor | |||||
| Net liabilities assumed upon closing of business combination | |||||
| Issuance of common stock to non-redeeming shareholders | |||||
| Unpaid capital project costs | |||||
| Unpaid land purchase costs | |||||
| Commitment and other fees for synthetic ATM | |||||
| Unpaid finance charge related to common stock issuance to lenders | |||||
| Finance charge related to Equity Kicker | |||||
| Reclass of advances to capital project costs | |||||
| Unpaid public offering issuance costs | |||||
| Incremental fair value of warrant inducement | |||||
| Issuance of common stock to short- term loan holders | |||||
| Issuance of common stock to PIPE investors | |||||
| Issuance of common stock to vendor | |||||
| Issuance of common stock under license arrangement | |||||
| Discount on convertible notes | |||||
Loading...